Discovery of potent SARS-CoV-2 nsp3 macrodomain inhibitors uncovers lack of translation to cellular antiviral response
Alpha A. Lee, Isabelle Amick, Jasmin Cara Aschenbrenner, Haim Michael Barr, Jared Benjamin, Alexander S. Brandis, Galit Cohen, Randy Diaz-Tapia, Shirly Duberstein, Jessica Dixon, David Cousins, M. Fairhead, D. Fearon, James Frick, James R. Gayvert, , Max Winokan
The paper identifies potent nsp3-mac1 inhibitors but finds they do not translate to antiviral activity in cell culture models.
bioRxiv · Aug 19, 2024 · PreprintMicrobiology